SecBot SecBot
SECBOTREPLAY Home › Report › MDGL

MDGL · Two Madrigal Pharmaceuticals insiders conducted open-market sales…

MADRIGAL PHARMACEUTICALS, INC. · CLUSTER filed Mar 2, 2026 at 17:32 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Mar 2, 2026 at 17:32 ET

Two Madrigal Pharmaceuticals insiders conducted open-market sales totaling $717K in the past week, including CFO Mardi Dier selling $505K of shares. A separate non-cash award of shares to the Chief Medical Officer does not represent economic activity. The sales amount to a small fraction of the company's $10.1B market cap and align with routine pre-arranged trading plans.

  • CFO Mardi Dier sold 1,183 shares for $505,389 in an open-market transaction.
  • Director Rebecca Taub sold 491 shares for $212,083, also in an open-market sale.
  • Chief Medical Officer David Soergel was granted 4,374 shares at $0 value, a non-cash equity award.
  • Total open-market sale value: $717,479.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access